MX9707391A - Composiciones de azatioprina para administracion colonica. - Google Patents
Composiciones de azatioprina para administracion colonica.Info
- Publication number
- MX9707391A MX9707391A MX9707391A MX9707391A MX9707391A MX 9707391 A MX9707391 A MX 9707391A MX 9707391 A MX9707391 A MX 9707391A MX 9707391 A MX9707391 A MX 9707391A MX 9707391 A MX9707391 A MX 9707391A
- Authority
- MX
- Mexico
- Prior art keywords
- azathioprine
- compositions
- colonic administration
- administration
- colonic
- Prior art date
Links
- LMEKQMALGUDUQG-UHFFFAOYSA-N azathioprine Chemical compound CN1C=NC([N+]([O-])=O)=C1SC1=NC=NC2=C1NC=N2 LMEKQMALGUDUQG-UHFFFAOYSA-N 0.000 title abstract 2
- 229960002170 azathioprine Drugs 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 230000000112 colonic effect Effects 0.000 title 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 abstract 1
- 210000001072 colon Anatomy 0.000 abstract 1
- 230000003111 delayed effect Effects 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/122—Foams; Dry foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Se proporciona un método para tratar enfermedad inflamatoria del intestino administrando topicamente al colon una cantidad efectiva de azatioprina o una sal farmacéuticamente aceptable de la misma, preferiblemente vía una formulacion para administracion oral o rectal de liberacion prolongada.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08413505 | 1995-03-30 | ||
| US08/413,505 US5691343A (en) | 1995-03-30 | 1995-03-30 | Use of topical azathioprine to treat inflammatory bowel disorders |
| PCT/US1996/003383 WO1996030021A1 (en) | 1995-03-30 | 1996-03-12 | Azathioprine compositions for colonic administration |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX9707391A true MX9707391A (es) | 1997-11-29 |
| MXPA97007391A MXPA97007391A (es) | 1998-07-03 |
Family
ID=
Also Published As
| Publication number | Publication date |
|---|---|
| PL322526A1 (en) | 1998-02-02 |
| AP727A (en) | 1999-01-29 |
| IS4561A (is) | 1997-09-18 |
| AP9701098A0 (en) | 1997-10-31 |
| NO974440L (no) | 1997-09-25 |
| EA199700282A1 (ru) | 1998-04-30 |
| AU707168B2 (en) | 1999-07-01 |
| HUP9801241A2 (hu) | 1998-09-28 |
| US5691343A (en) | 1997-11-25 |
| HUP9801241A3 (en) | 2000-06-28 |
| NO974440D0 (no) | 1997-09-25 |
| OA10517A (en) | 2002-04-24 |
| EP0817634A1 (en) | 1998-01-14 |
| NO20012930L (no) | 1997-09-25 |
| BR9607964A (pt) | 1999-11-30 |
| NZ306062A (en) | 1998-10-28 |
| CZ309297A3 (cs) | 1998-03-18 |
| NO311491B1 (no) | 2001-12-03 |
| CZ290428B6 (cs) | 2002-07-17 |
| US5905081A (en) | 1999-05-18 |
| CA2216728A1 (en) | 1996-10-03 |
| KR19980703423A (ko) | 1998-11-05 |
| NO20012930D0 (no) | 2001-06-13 |
| AU5421896A (en) | 1996-10-16 |
| TR199701079T1 (xx) | 1998-01-21 |
| JPH11502842A (ja) | 1999-03-09 |
| WO1996030021A1 (en) | 1996-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL328430A1 (en) | Intracolonic administration of nicotine for treating intestinal inflammatory diseases | |
| PT1452524E (pt) | Derivado de 2-oxo-1-pirrolidina e suas utilizações farmacêuticas | |
| UA40663C2 (uk) | Тверда фармацевтична композиція з регульованим вивільненням лікарського засобу для орального вживання | |
| SI0959888T1 (en) | Use of the chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease | |
| IL133623A0 (en) | Antithrombotic agents | |
| IL133627A0 (en) | Antithrombotic agents | |
| NO20012930L (no) | Azatioprinsammensetninger for tykktarmsadministrering | |
| NZ279062A (en) | Use of phenylazosalicylic acid derivatives for treatment/prevention of colon cancer | |
| GR3034186T3 (en) | 3,4-diarylchromans for treatment of dermatitis | |
| DE69824313D1 (de) | Sibutramin und orlistat enthaltende pharmazeutische zusammensetzungen | |
| CA2314154A1 (en) | Azepine or larger medium ring derivatives and their use as pharmaceuticals | |
| WO2000069520A3 (en) | Use of topical azathioprine to treat inflammatory bowel disorders | |
| MY113062A (en) | Amide derivatives and their therapeutic use | |
| AU2173101A (en) | Use of carboxy compounds such as 2(4-acetoxyphenyl)-2-chloro-N-methyl-ethylammonium chloride as anti-inflammatory agents | |
| BG106180A (en) | Pharmaceutical composition containing sibutramine and orlistat | |
| BG106209A (en) | Therapeutic agents | |
| IL146962A0 (en) | Aminotetralin derivatives for the therapy of cardiovascular diseases | |
| GB9420748D0 (en) | 1,5 benzodiazepine derivatives | |
| CA2180624A1 (en) | Diphenyl-1,2,3-thiadiazoles as anti-inflammatory agents | |
| MY133957A (en) | "compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor" | |
| ES477164A1 (es) | Un procedimiento de preparacion de 6-ciclopropil-1,3-dihi- dro-5-fenil-2-oxo-2h-tieno (2,3-e) diazepina. | |
| JPS56152420A (en) | Remedy for hypertension | |
| MX9703610A (es) | Nuevas (5,6)-heteroaril condensado-pirimidin-4-onas 2,3 disustituidas. | |
| RU96119990A (ru) | Новое применение соединений хинолин-3-карбоксамида |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration | ||
| MM | Annulment or lapse due to non-payment of fees |